De Lisle Partners LLP trimmed its position in Hawkins, Inc. (NASDAQ:HWKN – Free Report) by 15.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 82,119 shares of the specialty chemicals company’s stock after selling 15,300 shares during the quarter. Hawkins accounts for 1.5% of De Lisle Partners LLP’s holdings, making the stock its 12th largest holding. De Lisle Partners LLP’s holdings in Hawkins were worth $11,675,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the company. NewEdge Wealth LLC acquired a new position in shares of Hawkins during the third quarter worth $935,000. Envestnet Asset Management Inc. increased its holdings in shares of Hawkins by 74.6% during the third quarter. Envestnet Asset Management Inc. now owns 24,050 shares of the specialty chemicals company’s stock worth $4,394,000 after buying an additional 10,279 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Hawkins by 159.1% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 34,554 shares of the specialty chemicals company’s stock worth $5,020,000 after buying an additional 21,216 shares in the last quarter. Ascent Group LLC acquired a new position in shares of Hawkins during the fourth quarter worth $3,454,000. Finally, Aptus Capital Advisors LLC increased its holdings in shares of Hawkins by 15.2% during the third quarter. Aptus Capital Advisors LLC now owns 105,040 shares of the specialty chemicals company’s stock worth $19,193,000 after buying an additional 13,845 shares in the last quarter. 69.71% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts have recently issued reports on the stock. BWS Financial reiterated a “buy” rating and set a $200.00 price target on shares of Hawkins in a report on Monday, March 23rd. Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $200.00.
Hawkins Stock Performance
Shares of Hawkins stock opened at $158.34 on Friday. The company has a quick ratio of 1.46, a current ratio of 2.21 and a debt-to-equity ratio of 0.46. Hawkins, Inc. has a twelve month low of $117.98 and a twelve month high of $186.15. The stock has a market cap of $3.30 billion, a price-to-earnings ratio of 40.50, a P/E/G ratio of 2.83 and a beta of 0.76. The company’s fifty day moving average is $157.54 and its 200 day moving average is $149.07.
Hawkins (NASDAQ:HWKN – Get Free Report) last issued its quarterly earnings data on Wednesday, May 13th. The specialty chemicals company reported $0.74 earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.02). Hawkins had a return on equity of 16.08% and a net margin of 7.53%.The business had revenue of $265.91 million during the quarter, compared to the consensus estimate of $255.28 million. Sell-side analysts forecast that Hawkins, Inc. will post 4.27 EPS for the current year.
Hawkins Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were issued a dividend of $0.19 per share. The ex-dividend date was Friday, May 29th. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. Hawkins’s dividend payout ratio is currently 19.44%.
About Hawkins
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Featured Stories
- Five stocks we like better than Hawkins
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKN – Free Report).
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
